Experts warn about nutritional deficiencies with weight loss drugs
Exclusive Pharma Industry 4 min read After WHO nod, Indian Patient Groups urge GLP-1 inclusion in NLEM With the WHO recommending blockbuster GLP-1 therapies such as Semaglutide and Tirzepatide as essential medicines for diabetes, patient advocates in India are urging their inclusion in the National List of Essential Medicines (NLEM) to enable state procurement, free distribution, and wider affordability
Trained practitioners provide the appropriate amount, provide clean facilities, and observe for any untoward side effects
Additionally, the trial reported renal-related adverse events, including serious adverse events, at a higher rate compared to the placebo group
Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients
The lip is stabilized with hooks and fingers while incised with a No